Senior Director of Clinical Central, Proscia
Pathology solutions
Open for applications
Pathology solutions
21-100 employees
Open for applications
21-100 employees
Company mission
To perfect cancer diagnosis with intelligent software that changes the way the world practices pathology.
Role
Who you are
- Enterprise Sales Leadership: 7+ years in enterprise software sales into healthcare. Experience with AI-driven solutions is a strong plus
- Domain Knowledge: Familiarity with healthcare systems, diagnostics, or pathology preferred — but not required. Backgrounds in adjacent fields (radiology, molecular, etc.) are welcome
- Track Record: Consistently exceeded targets. Skilled in navigating complex accounts, building executive relationships, and driving strategic engagement
- Driven & Curious: Self-starter with a strong learning mindset. Comfortable in flat, fast-moving environments. Embraces AI tools to accelerate learning and sales velocity
- Plus: Advanced Degree (MS, PhD, MBA, MD) + Existing network in Pathology
- Adaptable: Willing to travel up to 40%. Fluent in business English, written and spoken. Thrives in dynamic, collaborative settings
What the job involves
- Territory: Central US and Canada
- Reports to: Vice President, Clinical Sales, North America
- As Proscia’s Sales Director, Clinical Central, you will own Proscia’s commercial strategy and execution for Clinical accounts in the Central region of North America, driving the adoption of our cutting-edge, AI native, enterprise digital pathology solutions in these accounts
- This role is ideal for a hungry and proven sales leader eager with the ability to engage the C-suite of our key prospects and deliver impactful results. Additional responsibilities include:
- Sales Strategy: Own and grow strategic clinical accounts across the Central region of North America, especially in the diagnostic lab networks, academic medical centers, and regional health systems
- Sales Execution: Drive rapid revenue growth and market share through a focused enterprise sales strategy while cultivating and leading executive relationships (e.g., Heads of Pathology, CIOs, CMOs, COOs) to position Proscia as the preferred partner
- Cross-Functional Collaboration: Partner cross-functionally with Marketing, Product, and Customer Success to accelerate GTM impact and adoption; Inform local marketing tactics with on-the-ground insights
- Enterprise Sales & Market Insights: Navigate complex deals using MEDDPICC or Challenger; maintain accurate forecasts in Salesforce; Track competitors and emerging opportunities to stay ahead of market shifts
- Be a visible champion of Proscia’s AI-powered vision — advancing diagnostics and improving patient outcomes
- Success in this role will require navigating complex, multi-stakeholder sales cycles involving key decision-makers and influencers such as the CIO, Head of Pathology, Chief Medical Officer, COO, and, in some cases, the CEO
- Your ability to build trust, tailor messaging to diverse priorities, and unify these stakeholders around Proscia’s value proposition will be critical to driving adoption and closing strategic deals
- This role has significant growth potential, positioning you to expand your responsibilities to bigger challenges. The right candidate will have the vision and drive to scale with the company and shape global sales strategies as Proscia continues its rapid expansion
Our take
Data suggests that whilst the number of people with cancer is expected to rise by 47% by 2040, the number of pathologists in the United States will decline by 17.53%. For this reason, there is a need to digitalise pathology. Proscia uses computing, visualisation and machine learning to aid pathologists towards diagnosing cancers.
Proscia is very well positioned in the explosive medicine market with its services currently being used by 10 of the top 20 pharmaceutical companies. The company has successfully developed algorithms using commercially available technology that reaches ‘substantial agreement’ with the human read, thereby cementing itself as a rare and much needed solution to the declining access to human pathologists.
Previous funding rounds saw Proscia launch new products, such as an automated quality control application that improves the efficiency of data-driven drug development. 2022 capital is broadening Proscia's portfolio of computational solutions, which in turn should strengthen its market and product leadership.
Steph
Company Specialist at Welcome to the Jungle
Insights
-13% employee growth in 12 months
Company
Funding (last 2 of 7 rounds)
Mar 2025
$50m
LATE VC
Mar 2024
$9m
SERIES C
Total funding: $129.3m
Company benefits
- Medical, dental, vision insurance
- Unlimited PTO
- Retirement plan options
- Commuter benefits
- Company sponsored short- and long-term disability plans
Company HQ
Center City West, Philadelphia, PA
Leadership
Coleman Stavish
(CTO)Previously worked as an Independent iOS Developer before joining Bombardier Transportation as a Software Engineering Co-op.
David West
(CEO)Prior to founding Proscia, received a Bachelor of Science in Bioengineering and Biomedical Engineering from The Johns Hopkins University.
Nathan Buchbinder
(CPO)Before acting as CPO, served as Vice President of Operations. Previously co-invented Design Team: The Cooling Cure and has been a Team Leader for Biliary and Pulmonary Brush Biopsy and Sleep Apnea Monitor Development.
Share this job
View 1 more job at Proscia